ICN-240

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameICN-240
Drug Alias NameICN-240
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsProstatic NeoplasmsLung NeoplasmsBreast Neoplasms +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBausch Health Companies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBausch Health Companies Inc
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsLung NeoplasmsBreast Neoplasms +[4

Other Information

ATC CodeN/A
Related LinksN/A